Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph 1, Antitumor Activity of AZD5991 w/ Relap/Refrac Haematologic Malignancies

Protocol: OSU-17152

Full Title

A Phase 1, Open-Label, Multicentre Study to Assess the Safety,Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of Ascending Doses of AZD5991 in Subjects with Relapsed or Refractory Haematologic Malignancies

Leukemia Multiple Myeloma